MedPath

Fortress Biotech

Fortress Biotech logo
🇺🇸United States
Ownership
Public
Established
2006-01-01
Employees
186
Market Cap
$46.7M
Website
http://www.fortressbiotech.com
Introduction

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

© Copyright 2025. All Rights Reserved by MedPath